Product Information
METHIMAZOLE 5 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0722 per EA under NDC 33342033511. Its NADAC has been published 117 times since Apr 3, 2024.
Strength
5 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342033511
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHIMAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA209827On Market Since
5/24/2023
Pharmacological Classes
Price Statistics
The NADAC for METHIMAZOLE 5 MG TABLET has been published 117 times since Apr 3, 2024, and over the history we have for it it has declined 21.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0722 per EA |
|---|---|
| All-time high | $0.0919 (Apr 10, 2024) |
| All-time low | $0.0661 (Nov 20, 2024) |
| 52-week high | $0.0864 |
| 52-week low | $0.0718 |
| Median price | $0.0761 |
| Average price | $0.0769 |
| Largest weekly change | -23.5% (Jul 17, 2024) |
| Weeks tracked | 117 |
| Tracking since | Apr 3, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHIMAZOLE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHIMAZOLE 5 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.0722 per EA (NDC 33342033511), effective Jun 24, 2026.
How has the price of METHIMAZOLE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHIMAZOLE 5 MG TABLET has declined 21.5%. It has been tracked across 117 weekly CMS publications since Apr 3, 2024.
What are the highest and lowest recorded NADAC prices for METHIMAZOLE 5 MG TABLET?
Since Apr 3, 2024, the NADAC for METHIMAZOLE 5 MG TABLET has ranged from a low of $0.0661 (Nov 20, 2024) to a high of $0.0919 (Apr 10, 2024), with a median of $0.0761 per EA.
Are there cheaper alternatives to METHIMAZOLE 5 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as METHIMAZOLE 5 MG TABLET, but none are currently priced below it.
Who manufactures METHIMAZOLE 5 MG TABLET?
METHIMAZOLE 5 MG TABLET (NDC 33342033511) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification